Minimally Invasive Neurosurgery Devices Market
Minimally Invasive Neurosurgery Devices uptake receiving traction amid Increasing Prevalence of Neurological Problems
Minimally Invasive Neurosurgery Devices Market by Device Type, Surgery Type & Region - Forecast 2022 – 2032
Minimally Invasive Neurosurgery Devices Market Snapshot (2022-2032)
[306 Pages Report] The global minimally invasive neurosurgery devices market is expected to be valued at US$ 3,073.9 Million in 2022. The consistent increase in medical research in the neurological areas drives market expansion. There is also a significant increase in the global elderly population, which would benefit more from these less invasive neurosurgical operations.
People's neurological problems have become more widespread and prevalent, increasing the demand for this treatment strategy. The overall demand for minimally invasive neurosurgery devices is projected to grow at a CAGR of 6.3% between 2022 and 2032, totaling around US$ 5,664.3 Million by 2032.
|
Data Points |
Key Statistics |
|
Minimally Invasive Neurosurgery Devices Market Value 2022 |
US$ 3,073.9 Million |
|
Minimally Invasive Neurosurgery Devices Market Projected Value (2032) |
US$ 5,664.3 Million |
|
Minimally Invasive Neurosurgery Devices Market CAGR (2022-2032) |
6.3% |
According to studies, about 17 million surgical procedures are performed each year. While operations have saved lives, the length of recovery time after surgery has long been a source of worry in the healthcare business. Patients are being treated differently as a result of minimally invasive procedures (MIS).
Furthermore, the healthcare business is hastening its move toward a patient-centric paradigm as convenience takes precedence. The worldwide minimally invasive neurosurgical devices market is expected to increase at a significant CAGR during the projected period, owing to these factors (2022-2032).
Let us know your requirement to get
100% FREE customization
Minimally Invasive Neurosurgery Devices Demand Analysis (2016 to 2021) Vs Market Outlook (2022 to 2032)
The global demand for minimally invasive neurosurgery devices is projected to increase at a CAGR of 6.3% during the forecast period between 2022 and 2032, reaching a total of US$ 5,664.3 Million in 2032, according to a report from Future Market Insights (FMI). From 2017 to 2021, sales witnessed significant growth, registering a CAGR of 5.1%.
Numerous innovation projects and research studies in the field of neurology are on the increase, bolstering market growth. Augmented reality and AI technologies are gradually being integrated into these minimally invasive treatments, which benefit both physicians and patients. The ease of recuperation and speedier healing after surgery make it a more effective therapeutic strategy. Many patients choose minimally invasive neurosurgery to traditional surgical treatments.
Furthermore, new product releases as a result of technical developments, partnerships, mergers, and acquisitions are significant strategic efforts made by industry participants that are projected to have a favorable influence on the market. As a result of the development of novel solutions, the market is likely to rise steadily throughout the forecast period.
For example, Fujifilm Medical Systems USA Inc. launched its ELUXEO surgical system in July 2020, which includes both the company's endoscopy and minimally invasive surgery portfolios and assists surgeons in performing flexible and rigid endoscopy from a single tower by providing better visualization. Moreover, rising awareness of the benefits of minimally invasive surgery and increased implementation of robotic-assisted surgical systems globally are likely to drive market expansion over the forecast period.
Which Drivers underpin Minimally Invasive Neurosurgery Devices Industry Expansion?
Rise in Neurological Problem Caseloads to Accelerate the Market Growth
The rise in neurological problem caseloads is largely driving the demand for minimally invasive neurosurgery equipment. According to UN News, around 1 billion people suffer from neurological illnesses, with roughly 6.8 million dying each year. Governments throughout the world are increasing their healthcare spending in response to the problem. Emerging nations' global healthcare expenditures will increase by up to 30% by 2022.
In the future, technology advances in neurology, such as robotic surgical systems and surgical navigation systems, will provide a healthy breeding environment for market participants. Furthermore, players are concentrating more on integrating high-tech solutions such as augmented reality (AR) and mixed reality (MR) into minimally invasive neurosurgical equipment.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhich Factors are limiting the Growth of Minimally Invasive Neurosurgery Devices Market?
Lack of Competent Specialists to Restrain the Market Growth
During their use, minimally invasive neurosurgical devices are quite complicated. The use of these technologies is hampered by a lack of competent specialists, particularly in emerging and underdeveloped nations.
The high price of minimally invasive neurosurgical equipment are once again limiting their use in treating patients. Furthermore, market participants are concerned about sluggish regulatory adoption and lenient reimbursement rules.
Region-wise Insights
Will North America Continue Dominance in the Global Minimally Invasive Neurosurgery Devices Market?
Rapid technical breakthroughs and improved healthcare facilities in the Region to Fuel the Market Growth
The minimally invasive neurosurgery devices market in North America is expected to accumulate the highest market share of 37.5% in 2022. North America continues to dominate the market for minimally invasive neurosurgical equipment.
Neurological illnesses impact over 25 million Americans and are acknowledged as a leading cause of mortality in the country. Rapid technical breakthroughs and improved healthcare facilities in North America are enticing people from all over the world to undergo minimally invasive neurosurgery.
Where does the growth of Minimally Invasive Neurosurgery Devices Market in Asia-Pacific stand?
Growing Patient Pool Undergoing Surgical Operations in the Region to Fuel the Market Growth
The minimally invasive neurosurgery devices market in Asia-Pacific is expected to accumulate a significant market share of 19% in 2022, and is expected to continue to maintain the trend over the forecast period as well.
In the next years, Asia Pacific (APAC) is expected to be the most profitable area in the minimally invasive neurosurgical devices market. The growing patient pool undergoing surgical operations, as well as government measures aimed at improving the healthcare sector, are driving regional market expansion.
Furthermore, the APAC market for uncommon neurological illness therapy is expanding rapidly. Artificial intelligence (AI) is being used by manufacturers of minimally invasive neurosurgical equipment to treat neurological problems.
How Will Growth of the Minimally Invasive Neurosurgery Devices Market unfold in Europe?
Rising Frequency of Lifestyle-Related and Chronic Ailments in the Region to Escalate Market Growth
The minimally invasive neurosurgery devices market in Europe is expected to accumulate a market share value of 28.7% in 2022. The rising frequency of lifestyle-related and chronic ailments, technical improvements, and a greater acceptance rate of minimally-invasive operations over traditional surgeries are the primary factors driving the growth of the Europe minimally-invasive surgical devices market.
Minimally invasive surgeries (MIS) result in reduced post-operative discomfort and need patients to take less pain relievers. Because there are few incisions or sutures, the hospital stay is usually brief, and patients do not need to return frequently. Furthermore, according to the European Society of Cardiology 2019 study, more than 11 million people in Europe suffer from cardiovascular disease each year (CVD).
With around 49 million individuals in Europe suffering from cardiovascular disease, the annual cost to European economies is considerable at EUR 210 billion. As a result of the benefits associated with minimally invasive operations, as well as the increased prevalence of chronic illnesses, the market's overall growth may accelerate throughout the projected period.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Category-wise Insights
By Surgery Type, which Minimally Invasive Neurosurgery Devices Category will remain prominent?
The Gastrointestinal Segment of the Minimally Invasive Neurosurgery Devices to beat Competition in Untiring Market
On the basis of surgery type, the global minimally invasive neurosurgery devices market is segmented into urological, vascular, cardiac, gynaecological, gastrointestinal, cosmetic, bariatric, thoracic, breast, orthopedic surgeries.
Due to the increased prevalence of gastrointestinal illnesses in young, adult, and elderly populations worldwide, the gastrointestinal segment is predicted to hold a significant market share and develop rapidly throughout the forecast period. Irritable bowel syndrome (IBS), Crohn's disease, peptic ulcers, and other disorders are related with the gastrointestinal system in the body, which includes the gastrointestinal tract, digestive tract, and alimentary canal. The increasing incidence of gastrointestinal illnesses is the key element driving the expansion of the market.
The Start-Up Ecosystem: How key Players are opening Frontiers for Future Growth?
As convenience has become the top priority, the medical industry is going to accelerate its transition toward a patient-centric approach. The international minimally invasive neurosurgical devices market is expected to increase significantly. Five major startups in this industry are:
- CroValve is a medical device startup focusing on creating a minimally invasive device to treat tricuspid regurgitation. They are situated in Dublin and have extensive clinical, technological, and commercial experience to assure a successful outcome. CroValve is creating a device that is safe, effective, and simple to use to drastically reduce tricuspid regurgitation in high risk patients.
- ClearCam is a company that creates equipment to improve surgeons' vision fields during minimally invasive surgeries. The KellingTM Device is an intra-operative lens cleaner that eliminates the requirement for the laparoscope to be removed from the body cavity for lens cleaning. KellingTM reduces treatment time while increasing safety for patients, surgeons, and surgical personnel. The gadget connects to the scope in seconds and does not require any additional supplies.
- Amplify Surgical, based in Irvine, California, is a privately held spinal device firm. The company focuses on developing and commercializing novel and minimally invasive spine surgical technology. IntuitiveX, a life science innovation incubator, has a portfolio business called Amplify Surgical.
- Moray Medical is aiming to enhance the lives of millions of people who have leaking heart valves. More cardiologists will be able to safely and affordably treat the enormous number of patients who require mitral valve clip therapy by utilizing our unique microfluidic robotics. Heart mitral valve repair is not widely available. The old standard of therapy, open-heart surgery, is very intrusive and hazardous for the great majority of those who might benefit. Transcatheter mitral valve operations with vein access are minimally invasive yet challenging to conduct. Low trauma treatment, on the other hand, works! Clip treatment, also known as Transcatheter Edge-to-Edge Repair (TEER), is quickly becoming the new standard of care.
- Neuroscience Novel Technologies SL (Neurostech) is a medtech & pharma firm that develops innovative medical equipment and pharmaceutical treatments for neurological diseases. We are especially devoted to neurodegenerative illnesses, a group of common ailments that impact millions of patients worldwide and for which there is now no cure. Our objective is to reduce illness progression and enhance patients' and families' quality of life. We have taken up the problem of brain medication delivery and are creating novel techniques to provide pharmaceuticals to those who need them. Our solutions are based on patented drug delivery technologies that are implantable and capable of delivering medications to the CNS. Following minimally invasive surgery to install the device, percutaneous access enables for simple dosing for long-term medication administration with greater efficacy and safety.
Who are the Leading Players in the Minimally Invasive Neurosurgery Devices Market?
Prominent players in the minimally invasive neurosurgery devices market are Karl Storz GmbH & Co. KG, Olympus Corporation, Conmed Corporation, Richard Wolf GmbH, Boston Scientific Inc., Integra LifeSciences Holdings Corporation, Aesculap Division, Smith & Nephew Plc, Medtronic and NICO Corp., among others.
Recent Developments:
- In October 2021, Conmed Corporation released HD Laparoscopes with greater picture quality and progressive sharpness for better observation of anatomical features.
- In June 2020, Karl Storz GmbH & Co. opened six examination rooms for Neurosurgery and ENT therapy at Paraguay's IPS Central Hospital.
Report Scope
|
Report Attribute |
Details |
|
Growth Rate |
CAGR of 6.3% from 2022-2032 |
|
Market Value in 2022 |
US$ 3,073.9 Million |
|
Market Value in 2032 |
US$ 5,664.3 Million |
|
Base Year for Estimation |
2021 |
|
Historical Data |
2016-2021 |
|
Forecast Period |
2022-2032 |
|
Quantitative Units |
Revenue in US$ Million and CAGR from 2022-2032 |
|
Report Coverage |
Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
|
Segments Covered |
|
|
Regions Covered |
|
|
Key Countries Profiled |
|
|
Key Companies Profiled |
|
|
Customization |
Available upon Request |
Key Segments Covered in the Minimally Invasive Neurosurgery Devices Industry Analysis
Minimally Invasive Neurosurgery Devices Market by Device Type:
- Minimally Invasive Surgical Devices
- Minimally Invasive Neurosurgery Monitoring & Visualization Devices
- Minimally Invasive Neurosurgery Endoscopy Devices
Minimally Invasive Neurosurgery Devices Market by Surgery Type:
- Minimally Invasive Urological Neurosurgery Devices
- Minimally Invasive Vascular Neurosurgery Devices
- Minimally Invasive Cardiac Neurosurgery Devices
- Minimally Invasive Gynaecological Neurosurgery Devices
- Minimally Invasive Gastrointestinal Neurosurgery Devices
- Minimally Invasive Cosmetic Neurosurgery Devices
- Minimally Invasive Bariatric Neurosurgery Devices
- Minimally Invasive Thoracic Neurosurgery Devices
- Minimally Invasive Breast Neurosurgery Devices
- Minimally Invasive Orthopedic Neurosurgery Devices
Minimally Invasive Neurosurgery Devices Market by Region:
- North America Minimally Invasive Neurosurgery Devices Market
- Latin America Minimally Invasive Neurosurgery Devices Market
- Europe Minimally Invasive Neurosurgery Devices Market
- Asia Pacific Minimally Invasive Neurosurgery Devices Market
- Middle East & Africa Minimally Invasive Neurosurgery Devices Market
Frequently Asked Questions
At what value did the minimally invasive neurosurgery devices market close in 2022?
By 2022-end, sales of minimally invasive neurosurgery devices closed at a value of US$ 3,073.9 Million
What was the last 5 years value CAGR for minimally invasive neurosurgery devices market value?
From 2016 to 2021, minimally invasive neurosurgery devices demand expanded at a CAGR of 5.1%
What is the projected forecast CAGR for the minimally invasive neurosurgery devices Industry from 2022-2032?
From 2022 to 2032, minimally invasive neurosurgery devices sales are expected to flourish at a CAGR of 6.3%
According to FMI, what is the anticipated market value for minimally invasive neurosurgery devices in 2032?
By 2032, the market value of minimally invasive neurosurgery devices is expected to reach US$ 5,664.3 Million
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2016-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) Analysis, 2016-2021 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2016-2021 and Forecast 2022-2032, By Device Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) Analysis By Device Type, 2016-2021 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Device Type, 2022-2032 5.3.1. Surgical Devices 5.3.2. Monitoring & Visualization Devices 5.3.3. Endoscopy Devices 5.4. Y-o-Y Growth Trend Analysis By Device Type, 2016-2021 5.5. Absolute $ Opportunity Analysis By Device Type, 2022-2032 6. Global Market Analysis 2016-2021 and Forecast 2022-2032, By Surgery Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) Analysis By Surgery Type, 2016-2021 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Surgery Type, 2022-2032 6.3.1. Urological 6.3.2. Vascular 6.3.3. Cardiac 6.3.4. Gynecological 6.3.5. Gastrointestinal 6.3.6. Cosmetic 6.3.7. Bariatric 6.3.8. Thoracic 6.3.9. Breast 6.3.10. Orthopedic Surgeries 6.4. Y-o-Y Growth Trend Analysis By Surgery Type, 2016-2021 6.5. Absolute $ Opportunity Analysis By Surgery Type, 2022-2032 7. Global Market Analysis 2016-2021 and Forecast 2022-2032, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2016-2021 7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. Asia Pacific 7.3.5. MEA 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2016-2021 and Forecast 2022-2032, By Country 8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021 8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 8.2.1. By Country 8.2.1.1. U.S. 8.2.1.2. Canada 8.2.2. By Device Type 8.2.3. By Surgery Type 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Device Type 8.3.3. By Surgery Type 8.4. Key Takeaways 9. Latin America Market Analysis 2016-2021 and Forecast 2022-2032, By Country 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Device Type 9.2.3. By Surgery Type 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Device Type 9.3.3. By Surgery Type 9.4. Key Takeaways 10. Europe Market Analysis 2016-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. U.K. 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Europe 10.2.2. By Device Type 10.2.3. By Surgery Type 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Device Type 10.3.3. By Surgery Type 10.4. Key Takeaways 11. Asia Pacific Market Analysis 2016-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. China 11.2.1.2. Japan 11.2.1.3. South Korea 11.2.1.4. India 11.2.1.5. Malaysia 11.2.1.6. Singapore 11.2.1.7. Australia 11.2.1.8. New Zealand 11.2.1.9. Rest of APAC 11.2.2. By Device Type 11.2.3. By Surgery Type 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Device Type 11.3.3. By Surgery Type 11.4. Key Takeaways 12. MEA Market Analysis 2016-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. GCC Countries 12.2.1.2. South Africa 12.2.1.3. Israel 12.2.1.4. Rest of MEA 12.2.2. By Device Type 12.2.3. By Surgery Type 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Device Type 12.3.3. By Surgery Type 12.4. Key Takeaways 13. Key Countries Market Analysis 13.1. U.S. 13.1.1. Pricing Analysis 13.1.2. Market Share Analysis, 2021 13.1.2.1. By Device Type 13.1.2.2. By Surgery Type 13.2. Canada 13.2.1. Pricing Analysis 13.2.2. Market Share Analysis, 2021 13.2.2.1. By Device Type 13.2.2.2. By Surgery Type 13.3. Brazil 13.3.1. Pricing Analysis 13.3.2. Market Share Analysis, 2021 13.3.2.1. By Device Type 13.3.2.2. By Surgery Type 13.4. Mexico 13.4.1. Pricing Analysis 13.4.2. Market Share Analysis, 2021 13.4.2.1. By Device Type 13.4.2.2. By Surgery Type 13.5. Germany 13.5.1. Pricing Analysis 13.5.2. Market Share Analysis, 2021 13.5.2.1. By Device Type 13.5.2.2. By Surgery Type 13.6. U.K. 13.6.1. Pricing Analysis 13.6.2. Market Share Analysis, 2021 13.6.2.1. By Device Type 13.6.2.2. By Surgery Type 13.7. France 13.7.1. Pricing Analysis 13.7.2. Market Share Analysis, 2021 13.7.2.1. By Device Type 13.7.2.2. By Surgery Type 13.8. Spain 13.8.1. Pricing Analysis 13.8.2. Market Share Analysis, 2021 13.8.2.1. By Device Type 13.8.2.2. By Surgery Type 13.9. Italy 13.9.1. Pricing Analysis 13.9.2. Market Share Analysis, 2021 13.9.2.1. By Device Type 13.9.2.2. By Surgery Type 13.10. China 13.10.1. Pricing Analysis 13.10.2. Market Share Analysis, 2021 13.10.2.1. By Device Type 13.10.2.2. By Surgery Type 13.11. Japan 13.11.1. Pricing Analysis 13.11.2. Market Share Analysis, 2021 13.11.2.1. By Device Type 13.11.2.2. By Surgery Type 13.12. South Korea 13.12.1. Pricing Analysis 13.12.2. Market Share Analysis, 2021 13.12.2.1. By Device Type 13.12.2.2. By Surgery Type 13.13. Malaysia 13.13.1. Pricing Analysis 13.13.2. Market Share Analysis, 2021 13.13.2.1. By Device Type 13.13.2.2. By Surgery Type 13.14. Singapore 13.14.1. Pricing Analysis 13.14.2. Market Share Analysis, 2021 13.14.2.1. By Device Type 13.14.2.2. By Surgery Type 13.15. Australia 13.15.1. Pricing Analysis 13.15.2. Market Share Analysis, 2021 13.15.2.1. By Device Type 13.15.2.2. By Surgery Type 13.16. New Zealand 13.16.1. Pricing Analysis 13.16.2. Market Share Analysis, 2021 13.16.2.1. By Device Type 13.16.2.2. By Surgery Type 13.17. GCC Countries 13.17.1. Pricing Analysis 13.17.2. Market Share Analysis, 2021 13.17.2.1. By Device Type 13.17.2.2. By Surgery Type 13.18. South Africa 13.18.1. Pricing Analysis 13.18.2. Market Share Analysis, 2021 13.18.2.1. By Device Type 13.18.2.2. By Surgery Type 13.19. Israel 13.19.1. Pricing Analysis 13.19.2. Market Share Analysis, 2021 13.19.2.1. By Device Type 13.19.2.2. By Surgery Type 14. Market Structure Analysis 14.1. Competition Dashboard 14.2. Competition Benchmarking 14.3. Market Share Analysis of Top Players 14.3.1. By Regional 14.3.2. By Device Type 14.3.3. By Surgery Type 15. Competition Analysis 15.1. Competition Deep Dive 15.1.1. Karl Storz GmbH & Co. KG 15.1.1.1. Overview 15.1.1.2. Product Portfolio 15.1.1.3. Profitability by Market Segments 15.1.1.4. Sales Footprint 15.1.1.4.1. Marketing Strategy 15.1.2. Olympus Corporation 15.1.2.1. Overview 15.1.2.2. Product Portfolio 15.1.2.3. Profitability by Market Segments 15.1.2.4. Sales Footprint 15.1.2.4.1. Marketing Strategy 15.1.3. Conmed Corporation 15.1.3.1. Overview 15.1.3.2. Product Portfolio 15.1.3.3. Profitability by Market Segments 15.1.3.4. Sales Footprint 15.1.3.4.1. Marketing Strategy 15.1.4. Richard Wolf GmbH 15.1.4.1. Overview 15.1.4.2. Product Portfolio 15.1.4.3. Profitability by Market Segments 15.1.4.4. Sales Footprint 15.1.4.4.1. Marketing Strategy 15.1.5. Boston Scientific Inc 15.1.5.1. Overview 15.1.5.2. Product Portfolio 15.1.5.3. Profitability by Market Segments 15.1.5.4. Sales Footprint 15.1.5.4.1. Marketing Strategy 15.1.6. Integra LifeSciences Holdings Corporation 15.1.6.1. Overview 15.1.6.2. Product Portfolio 15.1.6.3. Profitability by Market Segments 15.1.6.4. Sales Footprint 15.1.6.4.1. Marketing Strategy 15.1.7. Aesculap Division 15.1.7.1. Overview 15.1.7.2. Product Portfolio 15.1.7.3. Profitability by Market Segments 15.1.7.4. Sales Footprint 15.1.7.4.1. Marketing Strategy 15.1.8. Smith & Nephew Plc 15.1.8.1. Overview 15.1.8.2. Product Portfolio 15.1.8.3. Profitability by Market Segments 15.1.8.4. Sales Footprint 15.1.8.4.1. Marketing Strategy 15.1.9. Medtronic 15.1.9.1. Overview 15.1.9.2. Product Portfolio 15.1.9.3. Profitability by Market Segments 15.1.9.4. Sales Footprint 15.1.9.4.1. Marketing Strategy 15.1.10. NICO Corp. 15.1.10.1. Overview 15.1.10.2. Product Portfolio 15.1.10.3. Profitability by Market Segments 15.1.10.4. Sales Footprint 15.1.10.4.1. Marketing Strategy 16. Assumptions & Acronyms Used 17. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Market Value (US$ Mn) Forecast by Region, 2016-2032 Table 2: Global Market Value (US$ Mn) Forecast by Device Type, 2016-2032 Table 3: Global Market Value (US$ Mn) Forecast by Surgery Type, 2016-2032 Table 4: North America Market Value (US$ Mn) Forecast by Country, 2016-2032 Table 5: North America Market Value (US$ Mn) Forecast by Device Type, 2016-2032 Table 6: North America Market Value (US$ Mn) Forecast by Surgery Type, 2016-2032 Table 7: Latin America Market Value (US$ Mn) Forecast by Country, 2016-2032 Table 8: Latin America Market Value (US$ Mn) Forecast by Device Type, 2016-2032 Table 9: Latin America Market Value (US$ Mn) Forecast by Surgery Type, 2016-2032 Table 10: Europe Market Value (US$ Mn) Forecast by Country, 2016-2032 Table 11: Europe Market Value (US$ Mn) Forecast by Device Type, 2016-2032 Table 12: Europe Market Value (US$ Mn) Forecast by Surgery Type, 2016-2032 Table 13: Asia Pacific Market Value (US$ Mn) Forecast by Country, 2016-2032 Table 14: Asia Pacific Market Value (US$ Mn) Forecast by Device Type, 2016-2032 Table 15: Asia Pacific Market Value (US$ Mn) Forecast by Surgery Type, 2016-2032 Table 16: MEA Market Value (US$ Mn) Forecast by Country, 2016-2032 Table 17: MEA Market Value (US$ Mn) Forecast by Device Type, 2016-2032 Table 18: MEA Market Value (US$ Mn) Forecast by Surgery Type, 2016-2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Market Value (US$ Mn) by Device Type, 2022-2032 Figure 2: Global Market Value (US$ Mn) by Surgery Type, 2022-2032 Figure 3: Global Market Value (US$ Mn) by Region, 2022-2032 Figure 4: Global Market Value (US$ Mn) Analysis by Region, 2016-2032 Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032 Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032 Figure 7: Global Market Value (US$ Mn) Analysis by Device Type, 2016-2032 Figure 8: Global Market Value Share (%) and BPS Analysis by Device Type, 2022-2032 Figure 9: Global Market Y-o-Y Growth (%) Projections by Device Type, 2022-2032 Figure 10: Global Market Value (US$ Mn) Analysis by Surgery Type, 2016-2032 Figure 11: Global Market Value Share (%) and BPS Analysis by Surgery Type, 2022-2032 Figure 12: Global Market Y-o-Y Growth (%) Projections by Surgery Type, 2022-2032 Figure 13: Global Market Attractiveness by Device Type, 2022-2032 Figure 14: Global Market Attractiveness by Surgery Type, 2022-2032 Figure 15: Global Market Attractiveness by Region, 2022-2032 Figure 16: North America Market Value (US$ Mn) by Device Type, 2022-2032 Figure 17: North America Market Value (US$ Mn) by Surgery Type, 2022-2032 Figure 18: North America Market Value (US$ Mn) by Country, 2022-2032 Figure 19: North America Market Value (US$ Mn) Analysis by Country, 2016-2032 Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 22: North America Market Value (US$ Mn) Analysis by Device Type, 2016-2032 Figure 23: North America Market Value Share (%) and BPS Analysis by Device Type, 2022-2032 Figure 24: North America Market Y-o-Y Growth (%) Projections by Device Type, 2022-2032 Figure 25: North America Market Value (US$ Mn) Analysis by Surgery Type, 2016-2032 Figure 26: North America Market Value Share (%) and BPS Analysis by Surgery Type, 2022-2032 Figure 27: North America Market Y-o-Y Growth (%) Projections by Surgery Type, 2022-2032 Figure 28: North America Market Attractiveness by Device Type, 2022-2032 Figure 29: North America Market Attractiveness by Surgery Type, 2022-2032 Figure 30: North America Market Attractiveness by Country, 2022-2032 Figure 31: Latin America Market Value (US$ Mn) by Device Type, 2022-2032 Figure 32: Latin America Market Value (US$ Mn) by Surgery Type, 2022-2032 Figure 33: Latin America Market Value (US$ Mn) by Country, 2022-2032 Figure 34: Latin America Market Value (US$ Mn) Analysis by Country, 2016-2032 Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 37: Latin America Market Value (US$ Mn) Analysis by Device Type, 2016-2032 Figure 38: Latin America Market Value Share (%) and BPS Analysis by Device Type, 2022-2032 Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Device Type, 2022-2032 Figure 40: Latin America Market Value (US$ Mn) Analysis by Surgery Type, 2016-2032 Figure 41: Latin America Market Value Share (%) and BPS Analysis by Surgery Type, 2022-2032 Figure 42: Latin America Market Y-o-Y Growth (%) Projections by Surgery Type, 2022-2032 Figure 43: Latin America Market Attractiveness by Device Type, 2022-2032 Figure 44: Latin America Market Attractiveness by Surgery Type, 2022-2032 Figure 45: Latin America Market Attractiveness by Country, 2022-2032 Figure 46: Europe Market Value (US$ Mn) by Device Type, 2022-2032 Figure 47: Europe Market Value (US$ Mn) by Surgery Type, 2022-2032 Figure 48: Europe Market Value (US$ Mn) by Country, 2022-2032 Figure 49: Europe Market Value (US$ Mn) Analysis by Country, 2016-2032 Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 52: Europe Market Value (US$ Mn) Analysis by Device Type, 2016-2032 Figure 53: Europe Market Value Share (%) and BPS Analysis by Device Type, 2022-2032 Figure 54: Europe Market Y-o-Y Growth (%) Projections by Device Type, 2022-2032 Figure 55: Europe Market Value (US$ Mn) Analysis by Surgery Type, 2016-2032 Figure 56: Europe Market Value Share (%) and BPS Analysis by Surgery Type, 2022-2032 Figure 57: Europe Market Y-o-Y Growth (%) Projections by Surgery Type, 2022-2032 Figure 58: Europe Market Attractiveness by Device Type, 2022-2032 Figure 59: Europe Market Attractiveness by Surgery Type, 2022-2032 Figure 60: Europe Market Attractiveness by Country, 2022-2032 Figure 61: Asia Pacific Market Value (US$ Mn) by Device Type, 2022-2032 Figure 62: Asia Pacific Market Value (US$ Mn) by Surgery Type, 2022-2032 Figure 63: Asia Pacific Market Value (US$ Mn) by Country, 2022-2032 Figure 64: Asia Pacific Market Value (US$ Mn) Analysis by Country, 2016-2032 Figure 65: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 66: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 67: Asia Pacific Market Value (US$ Mn) Analysis by Device Type, 2016-2032 Figure 68: Asia Pacific Market Value Share (%) and BPS Analysis by Device Type, 2022-2032 Figure 69: Asia Pacific Market Y-o-Y Growth (%) Projections by Device Type, 2022-2032 Figure 70: Asia Pacific Market Value (US$ Mn) Analysis by Surgery Type, 2016-2032 Figure 71: Asia Pacific Market Value Share (%) and BPS Analysis by Surgery Type, 2022-2032 Figure 72: Asia Pacific Market Y-o-Y Growth (%) Projections by Surgery Type, 2022-2032 Figure 73: Asia Pacific Market Attractiveness by Device Type, 2022-2032 Figure 74: Asia Pacific Market Attractiveness by Surgery Type, 2022-2032 Figure 75: Asia Pacific Market Attractiveness by Country, 2022-2032 Figure 76: MEA Market Value (US$ Mn) by Device Type, 2022-2032 Figure 77: MEA Market Value (US$ Mn) by Surgery Type, 2022-2032 Figure 78: MEA Market Value (US$ Mn) by Country, 2022-2032 Figure 79: MEA Market Value (US$ Mn) Analysis by Country, 2016-2032 Figure 80: MEA Market Value Share (%) and BPS Analysis by Country, 2022-2032 Figure 81: MEA Market Y-o-Y Growth (%) Projections by Country, 2022-2032 Figure 82: MEA Market Value (US$ Mn) Analysis by Device Type, 2016-2032 Figure 83: MEA Market Value Share (%) and BPS Analysis by Device Type, 2022-2032 Figure 84: MEA Market Y-o-Y Growth (%) Projections by Device Type, 2022-2032 Figure 85: MEA Market Value (US$ Mn) Analysis by Surgery Type, 2016-2032 Figure 86: MEA Market Value Share (%) and BPS Analysis by Surgery Type, 2022-2032 Figure 87: MEA Market Y-o-Y Growth (%) Projections by Surgery Type, 2022-2032 Figure 88: MEA Market Attractiveness by Device Type, 2022-2032 Figure 89: MEA Market Attractiveness by Surgery Type, 2022-2032 Figure 90: MEA Market Attractiveness by Country, 2022-2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
